Hvad er CVR-nummeret på DANCANN PHARMA A/S?

DANCANN PHARMA A/S er registreret hos CVR / Virk under CVR 39426005.

Hvor mange medarbejdere har DANCANN PHARMA A/S?

DANCANN PHARMA A/S beskæftiger 7 personer pr. seneste årsrapport.

Carsten Trads er bestyrelsesformand i DANCANN PHARMA A/S, i rollen siden 2021.

DANCANN PHARMA A/Ss registrerede adresse er Rugvænget 5.

A/SActiveReklamebeskyttelse

CVR 39426005Rugvænget 5, 6823 AnsagerManufacture of pharmaceutical preparations· NACE 2120Est. 2018 · 8 years old7 employeeshttps://dancann.com

Aktivt ansatte i selskabet

Name	Role	Member since
Former (1)
PH Peter Hauberg Søndergaard Chief Executive Officer	Chief Executive Officer	2025 – 2026

Ikke-udøvende tilsyn

Name	Role	Member since
Current (4)
CC Christian Carlsen Deputy Chairman	Deputy Chairman	2022
JL Jes Lunde Board of Directors	Board of Directors	2024
JK Jeppe Krog Rasmussen Board of Directors	Board of Directors	2022
CT Carsten Trads Chairman	Chairman	2021
Former (5)
TØ Tue Østergaard Board of Directors	Board of Directors	2022 – 2023
PW Per Wester Board of Directors	Board of Directors	2020 – 2022
LB Louise Bertelsen Forman Board of Directors	Board of Directors	2023 – 2023
MØ Magnus Østergaard Dahlmann Chairman	Chairman	2020 – 2021
AS Alexander Schoeneck Board of Directors	Board of Directors	2022 – 2023

Pr. seneste årsrapport

Shareholder	Type	Ownership	Votes	Since
JEQ Capital AB	Individual	5–9.99%	5–9.99%	2024
Leif Andreas Johansson	Individual	5–9.99%	5–9.99%	2020
Nips Isolering ApS	Company	0%	0%	2019
VaVi Invest ApS	Company	0%	0%	2019
HeRoed ApS	Company	0%	0%	2019
XIGNOTUS CAPITAL ApS	Company	5–9.99%	5–9.99%	2022
Morten Martinsen	Individual	5–9.99%	5–9.99%	2019
JBJensen ApS	Company	0%	0%	2019
JJV Invest AB	Individual	5–9.99%	5–9.99%	2021
ABO Infinium Americas OpCo LTD.	Individual	25–33.32%	25–33.32%	2023
Futur Pension Försäkringsaktiebolag	Individual	5–9.99%	5–9.99%	2020
Alexander Schoeneck	Individual	5–9.99%	5–9.99%	2020

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.